Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer

Pancreatic cancer is associated with poor prognosis due to limited therapeutic options. Excision repair cross-complementing 3 (ERCC3) is an important member of nucleotide excision repair (NER) that is overexpressed in some cancers and may be regarded as a poor prognostic factor. Yet, its role in pan...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Cancer
Main Authors: Wang, Shujie, Liu, Wenjing, Ni, Yueli, Wang, Lifeng, Zhu, Yuzhi, Shi, Qiong, Yi, Zihan, Wang, Wenjie, Liu, Lili, Yang, Lijuan, Kuang, Yingmin, Zhu, Yuechun, Zhang, Qiao, Yang, Zhe
פורמט: Artigo
שפה:Inglês
יצא לאור: Ivyspring International Publisher 2021
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040713/
https://ncbi.nlm.nih.gov/pubmed/33854616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.54576
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים